RGEN
Repligen Corp
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Repligen Corp
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
SentenceFor example, we entered into a 15-year exclusive License Agreement with Daylight (the "Daylight Agreement"), giving us exclusive license and commercialization rights to use certain technology and intellectual property in bioprocessing.
RGEN 10-Kaccession 0001193125-26-076528
SentenceWe manufacture and exclusively supply the first of these ligands, NGL-Impact® A, to Purolite, for use with their Purolite Praesto Jetted A50 Protein A resin product.
RGEN 10-Kaccession 0001193125-26-076528
Repligen has 2 disclosed suppliers and 2 disclosed customers in SEC filings.
Repligen Corp
176.14
Expected move
No implied move.